IRIS
BARBANTI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 9.491
EU - Europa 8.240
NA - Nord America 4.927
SA - Sud America 821
AF - Africa 53
OC - Oceania 10
Totale 23.542
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 7.837
IE - Irlanda 5.955
US - Stati Uniti d'America 4.850
SG - Singapore 1.189
GB - Regno Unito 884
BR - Brasile 754
CH - Svizzera 405
FI - Finlandia 318
IT - Italia 208
DE - Germania 201
TR - Turchia 129
CN - Cina 92
FR - Francia 50
CA - Canada 44
EE - Estonia 40
IN - India 39
BD - Bangladesh 36
CZ - Repubblica Ceca 35
NL - Olanda 34
MX - Messico 26
KR - Corea 25
AR - Argentina 22
RU - Federazione Russa 22
PL - Polonia 21
ZA - Sudafrica 18
IQ - Iraq 17
EC - Ecuador 16
JP - Giappone 16
PK - Pakistan 15
UZ - Uzbekistan 14
AT - Austria 13
SE - Svezia 12
IR - Iran 11
UA - Ucraina 11
VN - Vietnam 11
ES - Italia 10
AU - Australia 9
EG - Egitto 9
MA - Marocco 9
IL - Israele 8
TW - Taiwan 8
CO - Colombia 6
VE - Venezuela 6
CL - Cile 5
KE - Kenya 5
NP - Nepal 5
SA - Arabia Saudita 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
ET - Etiopia 4
ID - Indonesia 4
JO - Giordania 4
LT - Lituania 4
PH - Filippine 4
PY - Paraguay 4
BE - Belgio 3
LV - Lettonia 3
PE - Perù 3
UG - Uganda 3
AM - Armenia 2
AZ - Azerbaigian 2
BB - Barbados 2
CY - Cipro 2
DK - Danimarca 2
LB - Libano 2
PS - Palestinian Territory 2
TH - Thailandia 2
TN - Tunisia 2
AL - Albania 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LY - Libia 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
TG - Togo 1
TT - Trinidad e Tobago 1
Totale 23.542
Salva come PNG Salva come JPEG
Città #
Hong Kong 7.836
Dublin 5.918
Ashburn 832
London 828
Boardman 807
Santa Clara 429
Zurich 405
Singapore 377
Dallas 334
Helsinki 308
The Dalles 274
Washington 197
Istanbul 110
Los Angeles 91
Assago 76
Munich 72
São Paulo 61
Chicago 39
San Francisco 30
Seattle 26
New York 25
Rio de Janeiro 25
Seoul 25
Frankfurt am Main 24
Belo Horizonte 22
Milan 22
Brno 21
Brooklyn 21
Montreal 17
Amsterdam 16
Brasília 16
Warsaw 16
Olomouc 14
Shanghai 14
Boston 13
Falkenstein 12
Stockholm 12
Catania 11
Johannesburg 11
Porto Alegre 11
Salvador 11
Tashkent 11
Tokyo 11
Atlanta 10
Chennai 10
Mexico City 10
Rome 10
Bexley 9
Clifton 9
Düsseldorf 9
Piscataway 9
Turku 9
Curitiba 8
Duque de Caxias 8
Fortaleza 8
Tappahannock 8
Columbus 7
Dhaka 7
Genoa 7
Manchester 7
Ottawa 7
Phoenix 7
Tanta 7
Canoas 6
Goiânia 6
Guayaquil 6
Karachi 6
Quito 6
Turin 6
Bauru 5
Campinas 5
Cipolletti 5
Guangzhou 5
Guarulhos 5
Joinville 5
Lauterbourg 5
Manaus 5
Nairobi 5
Osasco 5
Roubaix 5
São José dos Campos 5
Addis Ababa 4
Amman 4
Ankara 4
Bragança Paulista 4
Buenos Aires 4
Casablanca 4
Contagem 4
Erbil 4
Hanoi 4
Macapá 4
Maceió 4
Mascalucia 4
Montevideo 4
Moscow 4
Mumbai 4
New Delhi 4
North Bergen 4
Pelotas 4
Ribeirão Preto 4
Totale 19.769
Salva come PNG Salva come JPEG
Nome #
European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease 1.154
Prosthesis choice for transcatheter aortic valve replacement: Improved outcomes with the adoption of a patient-specific transcatheter heart valve selection algorithm 952
Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity score-matched analysis 942
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation 698
Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry 629
Embolic protection device in a patient with large left ventricular thrombus undergoing transcatheter aortic valve replacement 542
Transcathether aortic valve implantation with the new repositionable self-expandable Evolut R versus CoreValve system: A case-matched comparison 479
Predicting neocommissural orientation during TAVI workup 473
Aortic angle distribution and predictors of horizontal aorta in patients undergoing transcatheter aortic valve replacement 417
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation 364
Development and validation of the D-PACE scoring system to predict delayed high-grade conduction disturbances after transcatheter aortic valve implantation 353
Le nuove frontiere della cardiologia interventistica strutturale 342
1-Year Outcomes After Transfemoral Transcatheter or Surgical Aortic Valve Replacement: Results From the Italian OBSERVANT Study 145
Transcatheter or surgical treatment of severe aortic stenosis and coronary artery disease: A comparative analysis from the Italian OBSERVANT study 128
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 105
Transcatheter mitral valve implantation: CardiAQ 103
Antithrombotic therapy following transcatheter aortic valve implantation: what challenge do we face? 102
Transcatheter aortic valve replacement in obese patients: procedural vascular complications with the trans-femoral and trans-carotid access routes 100
Late Degeneration of Transcatheter Aortic Valves: Pathogenesis and Management 92
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation 88
Transcatheter aortic valve-in-valve implantation to treat aortic para-valvular regurgitation after TAVI 87
Procedural outcomes of the 34 mm EvolutR Transcatheter valve in a real-world population insights from the HORSE multicenter collaborative registry 87
Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation 85
Transcatheter Mitral Valve Implantation: CardiAQ-Edwards 85
Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis 85
Evaluation of current practices in transcatheter aortic valve implantation: The WRITTEN (WoRldwIde TAVI ExperieNce) survey 85
Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration 82
Clinical outcomes of transcatheter aortic valve implantation in patients younger than 70 years rejected for surgery: the AMTRAC registry 82
Impact of chronic kidney disease on outcomes after percutaneous mitral valve repair with the MitraClip system: insights from the GRASP registry 81
30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study 76
Functional and metabolic frailty predicts mortality in patients undergoing TAVI: Insights from the OBSERVANT II study 76
A novel, comprehensive tool for predicting 30-day mortality after surgical aortic valve replacement 74
Managing complications after transcatheter aortic valve implantation 71
Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registry 71
3-year outcomes of self-expanding Corevalve prosthesis - The Italian Registry 71
A Risk Model for Prediction of 1-Year Mortality in Patients Undergoing MitraClip Implantation 70
Acute kidney injury after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis: results from a large multicentre Italian research project 70
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 69
Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to high-risk transcatheter aortic valve implantation 69
Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Patients With Chronic Kidney Disease Stages 3b to 5 68
Early detection of transcatheter heart valve dysfunction 68
CharActeristics, sizing anD outcomes of stenotic, tapered, rapHe-type bicuspid aOrtic valves treated with trans-catheter device implantation: Insights the AD HOC registry 67
Early and Mid-Term Outcomes of Transcatheter Aortic Valve Replacement Using the New Generation Self-Expanding Corevalve Evolut R Device 67
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation 67
Clinical outcomes in women and men with small aortic annuli undergoing transcatheter aortic valve implantation: A multicenter, retrospective, propensity score-matched comparison 66
Predictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis 66
Cerebral embolization during transcatheter aortic valve implantation 66
Early and mid-term outcome of patients with low-flow-low-gradient aortic stenosis treated with newer-generation transcatheter aortic valves 66
The Helio transcatheter aortic dock for patients with aortic regurgitation 65
Management of severe stenosis controversies and promises 65
Safety and efficacy of drug eluting stents in patients with spontaneous coronary artery dissection 65
Early and late outcomes after transcatheter versus surgical aortic valve replacement in obese patients 65
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 64
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2 64
Transcatheter mitral valve repair: a brief review 63
Early and Midterm Outcome of Propensity-Matched Intermediate-Risk Patients Aged ≥80 Years With Aortic Stenosis Undergoing Surgical or Transcatheter Aortic Valve Replacement (from the Italian Multicenter OBSERVANT Study) 63
Pre-Defining Optimal C-Arm Position for TAVI With CT-Scan Using a Free Software 62
Comparison of Early and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with New York Heart Association Functional Class IV to those in Class III and Less 62
Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation 62
Bioprosthetic valves for transcatheter aortic valve replacement 62
Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve 62
One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry) 62
Early Adverse Impact of Transfusion After Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the TRITAVI Registry 62
Transcatheter aortic valve replacement with new-generation devices: A systematic review and meta-analysis 61
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement 61
Transcatheter aortic valve implantation compared with surgical aortic valve replacement in patients with anaemia 61
Sex Differences in Transfemoral Transcatheter Aortic Valve Replacement 61
Prespecified Risk Criteria Facilitate Adequate Discharge and Long-Term Outcomes After Transfemoral Transcatheter Aortic Valve Implantation 61
Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry 61
Permanent Pacemaker Implantation Following Valve-in-Valve Transcatheter Aortic Valve Replacement: VIVID Registry 61
[Transcatheter aortic valve implantation: are we ready? If so, for which patients? Is it sustainable? The interventional cardiologist's point of view] 61
Balloon-Expandable versus Self-Expandable Valves in Transcatheter Aortic Valve Implantation: Complications and Outcomes from a Large International Patient Cohort 61
Early Discharge After Transcatheter Aortic Valve Replacement: Mature Times 61
Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation 60
Perivalvular Extension of Infective Endocarditis After Transcatheter Aortic Valve Replacement 60
Predictors and safety of next-day discharge in patients undergoing transfemoral transcatheter aortic valve implantation 60
Long-term outcomes of concomitant transcatheter aortic valve implantation and percutaneous coronary intervention 60
Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation 60
OBSERVANT II: OBservational Study of Effectiveness of transcatheter aortic valve implantation with new geneRation deVices for severe Aortic steNosis Treatment. Study protocol 60
Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement 59
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 59
Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death 58
Unplanned Percutaneous Coronary Revascularization After TAVR: A Multicenter International Registry 58
Outcomes of Patients Undergoing Balloon Aortic Valvuloplasty in the TAVI Era: A Multicenter Registry 58
One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry 58
Protesi Percutanee Aortiche: Le indicazioni si allargano 58
Balloon Aortic Valvuloplasty in the Transcatheter Aortic Valve Replacement Era: A “Die-Hard” Procedure 58
Early discharge after transfemoral transcatheter aortic valve implantation 58
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry 57
Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis 57
Transcatheter aortic valve replacement in bicuspid aortic valve disease 57
Real-World Multiple Comparison of Transcatheter Aortic Valves: Insights From the Multicenter OBSERVANT II Study 57
Early Recovery of Left Ventricular Systolic Function after Transcatheter Aortic Valve Implantation 57
Plug-Based Endovascular Closure of Large Bore Aortofemoral Graft Arteriotomy for Transcatheter Aortic Valve Replacement 56
Clinical Outcomes and Prognosis Markers of Patients With Liver Disease Undergoing Transcatheter Aortic Valve Replacement: A Propensity Score-Matched Analysis 56
The failing right heart: implications and evolution in high-risk patients undergoing transcatheter aortic valve implantation 56
One-Year Outcomes after Surgical versus Transcatheter Aortic Valve Replacement with Newer Generation Devices 56
The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study 56
Unusual interatrial membrane in the left atrium: A newer obstacle for transseptal-based percutaneous mitral valve repair techniques? 56
Reduction of mitral valve regurgitation with Mitraclip® percutaneous system 55
Totale 13.403
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.397
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.397
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231.386 0 0 0 0 0 0 0 0 0 269 817 300
2023/20247.574 278 707 401 540 1.311 1.170 1.228 492 439 431 249 328
2024/202514.265 1.491 249 544 152 610 681 7.367 307 978 692 766 428
2025/2026743 743 0 0 0 0 0 0 0 0 0 0 0
Totale 23.968